Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177Paul D. Brown, Jan C. Buckner, Kurt A. Jaeckle et al.|Journal of Clinical Oncology|2008Cited by 275
Validation of EORTC Prognostic Factors for Adults With Low-Grade Glioma: A Report Using Intergroup 86-72-51T.B. Daniels, Edward G. Shaw, Paul D. Brown et al.|International Journal of Radiation Oncology*Biology*Physics|2011Cited by 137